The disease interval for DPR was found to harbor 230 genes associated with the condition. DPR and NFJS syndromes were specifically found to be differentiated from other syndromes by a mutation of the
keratin 14 gene, located on chromosome 17q21.2. This was found when keratin genes
KRT14,
KRT16, and
KRT17 were reassessed in 2006, revealing pathogenic mutations of
KRT14 in all patients with NFJS/DPR, displaying a strong correlation and suggesting a potential causation. The type of mutations observed were heterozygous
nonsense or
frameshift mutations, meaning the function of the gene was completely disrupted (missense is correlated with
EBS). The different phenotypic presentations of recessive (EBS-causing) versus dominant (NFJS/DPR-causing) premature truncation mutations in KRT14 are still unclear. The NFJS/DPR mutations were verified using two screening approaches, in which it was found that 17delG was absent from a panel of 100 control individuals, and C18X and Q7X were found to create a novel recognition site for the endonucleases DdeI and BfaI. Because the mutations were found to be heterozygous, the condition was concluded to be
autosomal dominant in its inheritance pattern. A study conducted on five families using a two-point linkage analysis of the combined genotyping data for three families across the NFJS/DPR candidate region generated an
LOD score of 6.2 at marker
D17S800, with a recombination score of 0. Further analysis revealed that NFJS may be caused by an identical founder mutation located within a 6-Mb interval between
D17S946 and
D17S2180. The disruption of the KRT14 gene in DPR suggests this gene is important during the early development of
dermatoglyphics and sweat glands. Because of the aforementioned genetic similarity between NFJS and DPR, some researchers have suggested treating the disorders as a single condition. == Diagnosis ==